This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: Innovations of Shohei Shiraishi in the Field of Imidazo[1,2-b]pyridazine Derivatives
Introduction
Shohei Shiraishi, an accomplished inventor based in Chigasaki, Japan, has made significant contributions to the field of medicinal chemistry through his innovative work on imidazo[1,2-b]pyridazine derivatives. With a total of two patents to his name, Shiraishi is recognized for developing industrially useful methods that enhance chemical production processes.
Latest Patents
Shiraishi's latest patents focus on a novel method for producing 3,6-disubstituted imidazo[1,2-b]pyridazine derivatives. This method utilizes 6-fluoroimidazo[1,2-b]pyridazine as a starting material and involves an aromatic substitution reaction that capitalizes on C—H activation through palladium. The innovation ensures a more efficient synthesis of these important chemical compounds, which have various applications in pharmaceuticals.
Career Highlights
Shohei Shiraishi works for Daiichi Sankyo Company, Limited, where he continues to push the boundaries of research and development in the pharmaceutical industry. His contributions have not only advanced the understanding of imidazo[1,2-b]pyridazine chemistry but also paved the way for new therapeutic agents.
Collaborations
Shiraishi collaborates with notable colleagues, including Ryoji Koike and Yoshifumi Hachisu, further enhancing the potential for innovative breakthroughs in their shared field of expertise. Their collective efforts in research demonstrate the importance of teamwork in driving scientific advancements.
Conclusion
Overall, Shohei Shiraishi’s work in developing methods for producing 3,6-disubstituted imidazo[1,2-b]pyridazine derivatives reflects his commitment to innovation and excellence in chemistry. His patents not only signify personal achievement but also contribute to the broader goals of improving pharmaceutical development and expanding research capabilities within the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
